Skip to content

Clinical trials

Recruiting Phase 2 Thrombocytopenia trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombocytopenia Phase: Phase 2 Status: Recruiting Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20201
20211
20221
20232
20242
20256
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Institute of Hematology & Blood Diseases Hospital, China2
Peking University People's Hospital2
Anhui Provincial Hospital1
Beijing Hospital1
Karyopharm Therapeutics Inc1
Medical University of Vienna1
Nantes University Hospital1
National Heart, Lung, and Blood Institute (NHLBI)1
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University1
Takeda1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombocytopenia15
Anemia2
Antiphospholipid Syndrome2
Pathologic Complete Response2
Primary Myelofibrosis2
Anemia, Aplastic1
Autoimmune Diseases1
Breast Neoplasms1
Carcinoma, Non-Small-Cell Lung1
Colorectal Neoplasms1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.